XLV240920P127000
- 0.01
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
Tandem Diabetes Rises as Insulin Pump Cleared for Use in EU With Lilly Insulin
Abbott a New Overweight at Piper Sandler; at Attractive Entry Point
Weight Loss Drug Developer BioAge Seeks up to $602M Valuation in U.S. IPO
Is the Federal Reserve starting an interest rate cut cycle on the cusp of a wave, possibly revealing the outcome of the election in advance?
Taking history as a lesson, in an election year with declining interest rates, the probability of the incumbent president or challenger winning is greater.
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
Johnson & Johnson Analyst Ratings
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Thermo Fisher Scientific Hosts 2024 Investor Day, Showcasing Industry-Leading Businesses, Proven Growth Strategy, And Strong Long-Term Financial Outlook
Vanda Slips as FDA Rejects Therapy for Stomach Condition
Abbott Laboratories Analyst Ratings
Several value stock ETFs have reached new highs! Will the uptrend continue with the start of the interest rate cut cycle?
Nomura Securities found that after studying historical rate-cut cycles, three months after the Fed cut interest rates by 50 basis points, the performance of value stocks outperformed growth stocks.
Unmissable investment strategy! The Federal Reserve officially enters a new era of interest rate cuts, these 6 industries have the most profitable potential.
Prepare yourself for the interest rate cut cycle.
BeiGene Initiated at Outperform at JMP Securities on Strength of Brukinsa
Merck's Keytruda Secures First FDA-Approval For Rare Form Aggressive Cancer
ResMed Slips as Wolfe Downgrades on GLP-1 Threat From Lilly
10 Health Care Stocks With Whale Alerts In Today's Session
Behind the Scenes of Merck & Co's Latest Options Trends
Sen. Sanders Says Generic Drugmakers Willing to Sell Ozempic for Less Than $100
Stocks Edge Lower As Fed Rate Decision Looms, Treasury Yields Rise As Odds Improve For Smaller Cut: What's Driving Markets Wednesday?